|
1
|
Wu CL, Ho JY, Chou SC and Yu DS: miR-429
reverses epithelial-mesenchymal transition by restoring E-cadherin
expression in bladder cancer. Oncotarget. 7:26593–26603.
2016.PubMed/NCBI
|
|
2
|
Rao Q, Chen Y, Yeh CR, Ding J, Li L, Chang
C and Yeh S: Recruited mast cells in the tumor microenvironment
enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2
EMT/MMP9 signals. Oncotarget. 7:7842–7855. 2016. View Article : Google Scholar
|
|
3
|
Wu CT, Chang YH, Lin P, Chen WC and Chen
MF: Thrombomodulin expression regulates tumorigenesis in bladder
cancer. BMC Cancer. 14:3752014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shirodkar SP and Lokeshwar VB: Potential
new urinary markers in the early detection of bladder cancer. Curr
Opin Urol. 19:488–493. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar
|
|
6
|
Yu H, Zeng J, Liang X, Wang W, Zhou Y, Sun
Y, Liu S, Li W, Chen C and Jia J: Helicobacter pylori promotes
epithelial-mesenchymal transition in gastric cancer by
downregulating programmed cell death protein 4 (PDCD4). PLoS One.
9:e1053062014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferraro A, Kontos CK, Boni T, Bantounas I,
Siakouli D, Kosmidou V, Vlassi M, Spyridakis Y, Tsipras I, Zografos
G, et al: Epigenetic regulation of miR-21 in colorectal cancer:
ITGB4 as a novel miR-21 target and a three-gene network
(miR-21-ITGβ4-PDCD4) as predictor of metastatic tumor potential.
Epigenetics. 9:129–141. 2014. View Article : Google Scholar
|
|
8
|
Brønnum H, Andersen DC, Schneider M,
Sandberg MB, Eskildsen T, Nielsen SB, Kalluri R and Sheikh SP:
miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of
epicardial mesothelial cells involving Programmed Cell Death 4 and
Sprouty-1. PLoS One. 8:e562802013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Q, Zhu J, Zhang Y, Sun Z, Guo X, Wang
X, Lee E, Bakthavatchalu V, Yang Q and Yang HS: Down-regulation of
programmed cell death 4 leads to epithelial to mesenchymal
transition and promotes metastasis in mice. Eur J Cancer.
49:1761–1770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Wu H, Lakdawala VS, Hu F, Hanson
ND and Miller AH: Inhibition of Jun N-terminal kinase (JNK)
enhances glucocorticoid receptor-mediated function in mouse
hippocampal HT22 cells. Neuropsychopharmacology. 30:242–249. 2005.
View Article : Google Scholar
|
|
11
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang Y, Wang Y, Wang Y, Meng Y, Zhu J, Jin
H, Li J, Zhang D, Yu Y, Wu XR, et al: A new tumour suppression
mechanism by p27Kip1: EGFR down-regulation mediated by JNK/c-Jun
pathway inhibition. Biochem J. 463:383–392. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gong Y, Qiu W, Ning X, Yang X, Liu L, Wang
Z, Lin J, Li X and Guo Y: CCDC34 is up-regulated in bladder cancer
and regulates bladder cancer cell proliferation, apoptosis and
migration. Oncotarget. 6:25856–25867. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen KH, Li CF, Chien LH, Huang CH, Su CC,
Liao AC and Wu TF: Role of galectin-1 in urinary bladder urothelial
carcinoma cell invasion through the JNK pathway. Cancer Sci.
107:1390–1398. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Subedi A, Kim MJ, Nepal S, Lee ES, Kim JA,
Sohn DH, Song K, Lee SH, Park WS, Jeong BS, et al: Globular
adiponectin modulates expression of programmed cell death 4 and
miR-21 in RAW 264.7 macrophages through the MAPK/NF-κB pathway.
FEBS Lett. 587:1556–1561. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Q, Zhang Y and Yang HS: Pdcd4
knockdown up-regulates MAP4K1 expression and activation of AP-1
dependent transcription through c-Myc. Biochim Biophys Acta.
1823:1807–1814. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Echevarría-Vargas IM, Valiyeva F and
Vivas-Mejía PE: Upregulation of miR-21 in cisplatin resistant
ovarian cancer via JNK-1/c-Jun pathway. PLoS One. 9:e970942014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song Y, Zhang P, Sun Y, Li X, Chen L, Xiao
Y and Xing Y: AMPK activation-dependent autophagy compromises
oleanolic acid-induced cytotoxicity in human bladder cancer cells.
Oncotarget. 8:67942–67954. 2017.PubMed/NCBI
|
|
19
|
Huang B, Zhang J, Zhang X, Huang C, Hu G,
Li S, Xie T, Liu M and Xu Y: Suppression of LETM1 by siRNA inhibits
cell proliferation and invasion of bladder cancer cells. Oncol Rep.
38:2935–2940. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei ZT, Zhang X, Wang XY, Gao F, Zhou CJ,
Zhu FL, Wang Q, Gao Q, Ma CH, Sun WS, et al: PDCD4 inhibits the
malignant phenotype of ovarian cancer cells. Cancer Sci.
100:1408–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luan Y, Liu J, Liu X, Xue X, Kong F, Sun
C, Wang J, Liu L and Jia H: Tetramethypyrazine inhibits renal cell
carcinoma cells through inhibition of NKG2D signaling pathways. Int
J Oncol. 49:1704–1712. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei X, Wang W, Wang L, Zhang Y, Zhang X,
Chen M, Wang F, Yu J, Ma Y and Sun G: MicroRNA-21 induces
5-fluorouracil resistance in human pancreatic cancer cells by
regulating PTEN and PDCD4. Cancer Med. 5:693–702. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Selaru FM, Olaru AV, Kan T, David S, Cheng
Y, Mori Y, Yang J, Paun B, Jin Z, Agarwal R, et al: MicroRNA-21 is
overexpressed in human cholangiocarcinoma and regulates programmed
cell death 4 and tissue inhibitor of metalloproteinase 3.
Hepatology. 49:1595–1601. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lei Y, Hu X, Li B, Peng M, Tong S, Zu X,
Wang Z, Qi L and Chen M: miR-150 modulates cisplatin
chemosensitivity and invasiveness of muscle-invasive bladder cancer
cells via targeting PDCD4 in vitro. Med Sci Monit. 20:1850–1857.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ferreira DM, Afonso MB, Rodrigues PM,
Simão AL, Pereira DM, Borralho PM, Rodrigues CM and Castro RE:
c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA
34a/sirtuin 1 pathway contributes to apoptosis induced by
deoxycholic acid in rat liver. Mol Cell Biol. 34:1100–1120. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yuan F, Xu Z, Yang M, Wei Q, Zhang Y, Yu
J, Zhi Y, Liu Y, Chen Z and Yang J: Overexpressed DNA polymerase
iota regulated by JNK/c-Jun contributes to hypermutagenesis in
bladder cancer. PLoS One. 8:e693172013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duan F, Yu Y, Guan R, Xu Z, Liang H and
Hong L: Vitamin K2 induces mitochondria-related apoptosis in human
bladder cancer cells via ROS and JNK/p38 MAPK Signal Pathways. PLoS
One. 11:e01618862016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Roth B, Jayaratna I, Sundi D, Cheng T,
Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M, et al:
Employing an orthotopic model to study the role of
epithelial-mesenchymal transition in bladder cancer metastasis.
Oncotarget. 8:34205–34222. 2017. View Article : Google Scholar :
|
|
29
|
Chaffer CL, Brennan JP, Slavin JL, Blick
T, Thompson EW and Williams ED: Mesenchymal-to-epithelial
transition facilitates bladder cancer metastasis: Role of
fibroblast growth factor receptor-2. Cancer Res. 66:11271–11278.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hulit J, Suyama K, Chung S, Keren R,
Agiostratidou G, Shan W, Dong X, Williams TM, Lisanti MP, Knudsen
K, et al: N-cadherin signaling potentiates mammary tumor metastasis
via enhanced extracellular signal-regulated kinase activation.
Cancer Res. 67:3106–3116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baek SH, Ko JH, Lee JH, Kim C, Lee H, Nam
D, Lee J, Lee SG, Yang WM, Um JY, et al: Ginkgolic acid inhibits
invasion and migration and TGF-β-induced EMT of lung cancer cells
through PI3K/Akt/mTOR inactivation. J Cell Physiol. 232:346–354.
2017. View Article : Google Scholar
|
|
32
|
Vos MC, Hollemans E, Ezendam N, Feijen H,
Boll D, Pijlman B, van der Putten H, Klinkhamer P, van Kuppevelt
TH, van der Wurff AA, et al: MMP-14 and CD44 in
epithelial-to-mesenchymal transition (EMT) in ovarian cancer. J
Ovarian Res. 9:532016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zeng Y, Yao X, Chen L, Yan Z, Liu J, Zhang
Y, Feng T, Wu J and Liu X: Sphingosine-1-phosphate induced
epithelial-mesenchymal transition of hepatocellular carcinoma via
an MMP-7/syndecan-1/TGF-β autocrine loop. Oncotarget.
7:63324–63337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu CL, Ho JY, Chou SC and Yu DS: miR-429
reverses epithelial-mesenchymal transition by restoring E-cadherin
expression in bladder cancer. Oncotarget. 7:26593–26603.
2016.PubMed/NCBI
|
|
35
|
Wang R, Ke ZF, Wang F, Zhang WH, Wang YF,
Li SH and Wang LT: GOLPH3 overexpression is closely correlated with
poor prognosis in human non-small cell lung cancer and mediates its
metastasis through upregulating MMP-2 and MMP-9. Cell Physiol
Biochem. 35:969–982. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song H, Pan D, Sun W, Gu C, Zhang Y, Zhao
P, Qi Z and Zhao S: SiRNA directed against annexin II receptor
inhibits angiogenesis via suppressing MMP2 and MMP9 expression.
Cell Physiol Biochem. 35:875–884. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cheng HL, Lin CW, Yang JS, Hsieh MJ, Yang
SF and Lu KH: Zoledronate blocks geranylgeranylation not
farnesylation to suppress human osteosarcoma U2OS cells metastasis
by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.
Oncotarget. 7:9742–9758. 2016.PubMed/NCBI
|
|
38
|
Lee YS, Kim SY, Song SJ, Hong HK, Lee Y,
Oh BY, Lee WY and Cho YB: Crosstalk between CCL7 and CCR3 promotes
metastasis of colon cancer cells via ERK-JNK signaling pathways.
Oncotarget. 7:36842–36853. 2016.PubMed/NCBI
|
|
39
|
Ebelt ND, Cantrell MA and Van Den Berg CL:
c-Jun N-terminal kinases mediate a wide range of targets in the
metastatic cascade. Genes Cancer. 4:378–387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ji J, Jia S, Jia Y, Ji K, Hargest R and
Jiang WG: WISP-2 in human gastric cancer and its potential
metastatic suppressor role in gastric cancer cells mediated by JNK
and PLC-γ pathways. Br J Cancer. 113:921–933. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ma W, Gilligan BM, Yuan J and Li T:
Current status and perspectives in translational biomarker research
for PD-1/PD-L1 immune checkpoint blockade therapy. J Hematol Oncol.
9:472016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu B, Song Y and Liu D: Recent
development in clinical applications of PD-1 and PD-L1 antibodies
for cancer immunotherapy. J Hematol Oncol. 10:1742017. View Article : Google Scholar : PubMed/NCBI
|
